Incyte
INCY
358 hedge funds and large institutions have $12.9B invested in Incyte in 2016 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 138 increasing their positions, 128 reducing their positions, and 73 closing their positions.
112% more call options, than puts
Call options by funds: $81.9M | Put options by funds: $38.6M
8% more repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 128
6% less funds holding
Funds holding: 380 → 358 (-22)
27% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 73
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
32% less capital invested
Capital invested by funds: $18.9B → $12.9B (-$6.06B)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$218M |
| 2 |
JP Morgan Chase
New York
|
-$154M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$114M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$110M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$81.8M |
INCY Hedge Fund Activity: Q1 2016 in Review
358 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q1 2016, worth a combined $12.9B — down 32% from $18.9B a quarter earlier.
Sellers outnumbered buyers: 73 funds closed out of INCY and 53 opened new positions — a net loss of 20 holders — while 128 trimmed existing stakes and 138 added.
The largest buyer was Wellington Management Group, adding an estimated $923M. The largest seller was T. Rowe Price Associates, cutting an estimated $218M.
- 358 institutional investors held Incyte (INCY) as of Q1 2016, down from 380 in Q4 2015.
- Funds reported $12.9B of Incyte stock for Q1 2016, down 32% quarter-over-quarter.
- 53 funds opened new Incyte positions in Q1 2016 and 73 closed out, a net change of -20 holders.
- The largest Incyte buyer in Q1 2016 was Wellington Management Group, an estimated $923M added.
- The largest Incyte seller in Q1 2016 was T. Rowe Price Associates, an estimated $218M sold.
Based on aggregated 13F filings for Q1 2016.